DelveInsight's analysis indicates a promising outlook for the dry eye disease market from 2024 to 2034, with positive growth anticipated. This growth trajectory is attributed to the emergence ...

Other developments in the ophthalmic sector this year included the Alcon/Aerie deal (estimated ... being to expand into the ophthalmic pharmaceutical eye drop space. As the race to deliver ...

Citing people familiar with the matter, the FT reports that Blackstone is likely to drop out of the ... as well as ophthalmic pharmaceuticals, intraocular lenses, and eye surgery products, and ...

A couple drops in your eye usually brings relief, not concern—but a rare recall case highlights the importance of a clean, sterile bottle.

DelveInsight's Dry Eye Disease Market Insights report includes a comprehensive understanding of current treatment practices, ...

Alcon Research LLC lost its court bid Tuesday to veto a public listing by Aurion Biotech Inc., a business it’s backing, but ...

KeyBanc lowered the firm’s price target on Alcon (ALC) to $105 from $107 and keeps an Overweight rating on the shares. The firm remains ...

Needham analyst David Saxon lowered the firm’s price target on Alcon (ALC) to $106 from $108 and keeps a Buy rating on the shares. The firm is ...

Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Vertex Pharmaceuticals. Recent revisions tend to reflect the latest near-term business trends.

SANTA FE, N.M. — Tributes are pouring in for former New Mexico State Rep. Eliseo Alcon, who died of liver cancer Monday. New Mexico House Democrats issued a press release confirming Rep.

Jan. 13—Former New Mexico Rep. Eliseo Lee Alcon, a prominent Democrat from Milan who received a Bronze Star for his service as a combat medic in the Army during the Vietnam War, died Monday ...